Kangso Medical Inspection

Kangso Medical Inspection, headquartered in Beijing, China, was founded in 2013 by Wei Wei, who has been involved in the medical field prior to establishing this firm.Kangso Medical Laboratory specializes in medical testing and diagnostics, providing core services that enhance patient outcomes through accurate and timely results. Their primary offerings include a variety of clinical laboratory tests and analyses that facilitate disease diagnosis, monitoring, and management for healthcare professionals. By utilizing advanced technologies in molecular biology and biochemistry, Kangso addresses healthcare challenges such as early disease detection and personalized medicine. Their client base includes hospitals and clinics across urban centers in China, targeting major metropolitan areas like Beijing and Shanghai, where there is a high demand for quality diagnostic services.Kangso Medical Laboratory generates revenue through direct service agreements with healthcare providers, such as hospitals and clinics, on a fee-for-service basis. Clients are billed for specific tests performed and results provided. The company also engages in partnerships for bulk testing services with larger institutions, resulting in negotiated pricing. Each service is priced according to its complexity and resource requirements, aligning with industry standards for laboratory diagnostics. The company is working on launching innovative diagnostic tests aimed at improving early detection of diseases and personalized medicine solutions. Additionally, Kangso is targeting expansion into other major cities across China, aiming for significant market penetration by 2025, in response to increasing healthcare demands.

1. Series A

   Aug 20, 2018

   Amount

   Undisclosed

   Investors

   Locked

2. Series A

   Jan 25, 2016

   Amount

   Undisclosed

   Investors

   Locked